APP13007

· Formosa Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for APP13007, covering 2023-06-27 to 2023-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study [Phase 3]

See pricing